You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 19, 2024

Q-PAM Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Q-pam, and when can generic versions of Q-pam launch?

Q-pam is a drug marketed by Quantum Pharmics and is included in six NDAs.

The generic ingredient in Q-PAM is diazepam. There are eight drug master file entries for this compound. Forty-two suppliers are listed for this compound. Additional details are available on the diazepam profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Q-pam

A generic version of Q-PAM was approved as diazepam by MYLAN on September 4th, 1985.

  Try a Trial

Drug patent expirations by year for Q-PAM
Anatomical Therapeutic Chemical (ATC) Classes for Q-PAM

US Patents and Regulatory Information for Q-PAM

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Quantum Pharmics Q-PAM diazepam TABLET;ORAL 070423-001 Dec 12, 1985 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Quantum Pharmics Q-PAM diazepam TABLET;ORAL 072432-001 Apr 29, 1988 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Quantum Pharmics Q-PAM diazepam TABLET;ORAL 072431-001 Apr 29, 1988 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Quantum Pharmics Q-PAM diazepam TABLET;ORAL 070424-001 Dec 12, 1985 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Quantum Pharmics Q-PAM diazepam TABLET;ORAL 072433-001 Apr 29, 1988 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Quantum Pharmics Q-PAM diazepam TABLET;ORAL 070425-001 Dec 12, 1985 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.